InsidersTradesSigma
Follow the 海昌生技 stock price and the full directors' dealings record of the company, a listed equity based in Taiwan. Shares trade on the TW market, under the authority of TWSE / TPEx (MOPS). The latest transaction was filed on 8 July 2026 (Transfer). Among the most active insiders: 寄生股份有限公司. Every trade is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
海昌生技 is a company listed on the XTAI, specializing in the biotechnology sector. It focuses on developing innovative health solutions.